Race Oncology Limited (ASX:RAC)
Australia · Delayed Price · Currency is AUD 3.130
+0.020 (0.64%)
Sep 26, 2025, 4:10 PM AEST
Race Oncology Market Cap
Race Oncology has a market cap or net worth of 544.00 million as of September 26, 2025. Its market cap has increased by 87.77% in one year.
Market Cap
544.00M
Enterprise Value
530.34M
Revenue
6.04M
Ranking
n/a
PE Ratio
n/a
Stock Price
3.13
Market Cap Chart
Since July 13, 2016, Race Oncology's market cap has increased from 12.64M to 544.00M, an increase of 4,204.77%. That is a compound annual growth rate of 50.45%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 26, 2025 | 544.00M | 131.97% |
| Dec 31, 2024 | 234.51M | 70.76% |
| Dec 29, 2023 | 137.34M | -57.61% |
| Dec 30, 2022 | 324.00M | -43.55% |
| Dec 31, 2021 | 574.00M | 153.36% |
| Dec 31, 2020 | 226.55M | 992.48% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2016 | Upgrade Pro | Upgrade Pro |
| Jul 13, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CSL Limited | 95.78B |
| Pro Medicus | 32.31B |
| Cochlear | 18.65B |
| Sonic Healthcare | 10.64B |
| Ramsay Health Care | 7.37B |
| Telix Pharmaceuticals | 5.20B |
| Ansell | 4.62B |
| Mesoblast | 3.19B |